Month: November 2021

Nov 07 2021

Uncategorized

Schizophrenia drug landscape: a stagnant field on the cusp of change?

by Clinical Editor

No Comments

Several pipeline therapies could shake up the schizophrenia field, but their road through development is unlikely to be an easy path. Most new drugs in schizophrenia have relied on similar...

Nov 07 2021

Uncategorized

Antipsychotic Patch Quiets Schizophrenia-Related Hostility

by Clinical Editor

No Comments

The antipsychotic “patch” effectively reduced hostility among patients with schizophrenia, a researcher reported. In a post-hoc analysis of a phase III trial, once-daily asenapine transdermal system …

Nov 07 2021

Uncategorized

Here’s why people with depression and schizophrenia need COVID-19 boosters now

by Clinical Editor

No Comments

Having mood disorders, including depression, and schizophrenia spectrum disorders can make you more likely to get severely ill from COVID-19,” the agency explained on its website. This is huge. It...

Nov 07 2021

Uncategorized

Schizophrenia burden totaled more than $340 billion in 2019

by Clinical Editor

No Comments

Schizophrenia’s approximate societal burden was $341.5 billion in the U.S. in 2019, according to study results presented at Psych Congress.Adjusted for inflation, this represented a 99.8% increase in …

Nov 06 2021

Uncategorized

Antipsychotics and New-Onset Obsessive-Compulsive Disorder in Schizophrenia

by Clinical Editor

No Comments

Comorbidity or medication adverse effect? Researchers performed a nested case-control study of new-onset obsessive-compulsive disorder following antipsychotic use in schizophrenia.

Nov 06 2021

Uncategorized

Schizophrenia drug landscape: a stagnant field on the cusp of change?

by Clinical Editor

No Comments

Several pipeline therapies could shake up the schizophrenia field, but their road through development is unlikely to be an easy path. Most new drugs in schizophrenia have relied on similar...

Nov 06 2021

Uncategorized

Antipsychotic Patch Quiets Schizophrenia-Related Hostility

by Clinical Editor

No Comments

The antipsychotic “patch” effectively reduced hostility among patients with schizophrenia, a researcher reported. In a post-hoc analysis of a phase III trial, once-daily asenapine transdermal system …

Nov 06 2021

Uncategorized

Schizophrenia burden totaled more than $340 billion in 2019

by Clinical Editor

No Comments

Schizophrenia’s approximate societal burden was $341.5 billion in the U.S. in 2019, according to study results presented at Psych Congress.Adjusted for inflation, this represented a 99.8% increase in …

Nov 06 2021

Uncategorized

COVID Doesn’t Dampen LAI Antipsychotic Prescribing in Schizophrenia

by Clinical Editor

No Comments

Of the prescribers who responded to the survey, 59.8% said that they did not see any increases or decreases in their 2020 prescribing trends. Among this majority, most concerns about...

Nov 05 2021

Uncategorized

Schizophrenia burden totaled more than $340 billion in 2019

by Clinical Editor

No Comments

Schizophrenia’s approximate societal burden was $341.5 billion in the U.S. in 2019, according to study results presented at Psych Congress.Adjusted for inflation, this represented a 99.8% increase in …